Horizon builds human disease models and reagents derived from genetically-engineered cells that its customers use, or that are deployed on their behalf to: gain knowledge of the genetic drivers of disease; develop novel drugs or cell therapies targeted.
Cytokinetics
21 followers
Iovance Biotherapeutics
10 followers
Squarepoint Capital
55 followers
Premier Research
4 followers
BioAgilytix
3 followers
Quanterix
3 followers
Xencor
3 followers
FUJIFILM Diosynth Biotechnologies
33 followers
Recursion Pharmaceuticals
20 followers
Abzena
2 followers
BioLegend, Inc.
2 followers
Heron Therapeutics
2 followers